Return to Course LibraryCE InformationBibliographyRegister Now

Release Date:
April 22, 2015

Expiration Date:
May 1, 2018

 

 

 

FACULTY


 

John M. Lewin, MD, FACR
Breast Imaging Specialist
Diversified Radiology of Colorado, PC
Medical Director
Rose Breast Center
Denver, CO

 


 

 

 

Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0


 


 

Contrast-enhanced Digital Mammography

 

Recording of a live webinar presented on March 26, 2015


A certified one-hour archived webinar for radiologists and radiologic technologists, and other healthcare professionals who care for patients with breast disease

 

Format: Archived Webinar
Credit:  1.0 AMA PRA Category 1
Credit:  1.0 ARRT Category A
Fee for Credit Certificate: $0


 

Click ENROLL NOW to register for this program


Course Overview
In an era of high demand for breast screening exams, clinicians are continually looking for safe and effective breast cancer screening tools. This webinar will cover the history and technological components of contrast-enhanced digital mammography (CEDM), its potential uses, and impact on patients and clinical practice. Faculty will discuss the practicality of this adjunct modality, followed by case review.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Evaluate the role of contrast-enhanced digital mammography as an adjunct to full-field digital mammography for supplemental diagnostic breast imaging
  • Identify the patient cohorts who may benefit from contrast-enhanced digital mammography
  • Describe the educational and operation issues, as well as benefits and risks, of integrating CEDM into clinical practice

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Physicians

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to http://www.uems.eu/uems-activities/accreditation/eaccme.

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
This program is offered by ICPME through WebEx webinar service. There are no fees or prerequisites for this program.

  • Click ENROLL NOW, then CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
  • Click the blue link. Complete the precourse evaluation, then click SUBMIT.
  • Once the precourse evaluation is submitted, click on the blue link again to view the course.
  • Click on PLAYBACK. To view the streaming video, you may have to download WebEx Player or JAVA.

Credit
Your online account with ICPME serves as a permanent record of credit certificates earned through www.icpme.us

  • Log-in to your account at www.icpme.us
  • View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
  • At the conclusion of the lecture, close the WebEx Player window.
  • From the COURSE HOME page, click the buttons for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account on www.icpme.us

Your certificate of credit will remain in your account at www.icpme.us as a permanent record of your participation.


Faculty

John M. Lewin, MD, FACR
Dr. Lewin received his medical degree from Harvard University School of Medicine and completed his residency and fellowship in diagnostic radiology at University of Colorado Health Sciences Center.

Prior to joining Diversified Radiology of Colorado and Rose Breast Center, Dr. Lewin was Associate Professor of Radiology at the University of Colorado School of Medicine. During that time his research focused on the clinical introduction of full-field digital mammography. Using one of the earliest full-field digital mammography prototypes, he conducted the first large clinical trial comparing this new technology to film mammography for breast cancer screening. In 1999, Dr. Lewin obtained grant funding to study the use of intravenous contrast agents with digital mammography, leading to the development and clinical demonstration of dual-energy contrast-enhanced digital mammography (CEDM).  Since that time, Dr. Lewin has continued to study both the technical and clinical aspects of CEDM to improve and refine the technique and has lectured on the subject at national and international meetings. 

Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

John M. Lewin, MD, FACR has received fees for consulting and contracted research from Hologic, Inc.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino 
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CCMEP
Linda McLean, MS 
Victoria Phoenix, BS           
Jan Schultz, RN, MSN, CCMEP
Judi Smelker-Mitchek, RN, BSN                         

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 X10


Jointly provided by

               
 
 

This activity is supported by an educational grant from HOLOGIC, INC.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.